Pure Global AI
NCT06231316Not yet recruiting

Preventing Hypotension in the Spine During Cesarean Delivery.

Preventing Spinal Hypotension During Cesarean Birth With Two Initial Boluses of Norepinephrine
Assiut UniversityClinicalTrials.govdrug
Verified
Study focus
Disease/Condition
Anesthesia
Drug/Device/Intervention
Norepinephrine Injection
Study type
Observational
Intervention type
drug
Sponsor & location
Primary sponsor
Assiut University
Timeline & enrollment
Phase
N/A
Start date
Mar 01, 2024
End date
May 01, 2025
Enrollment
100 participants
Primary outcome

The frequency of postspinal hypotension

Summary

Examining the advantages associated with the utilization of noradrenaline in preventing
 spinal hypotension during cesarean births. This involves assessing the positive outcomes and
 potential benefits derived from incorporating noradrenaline into the medical approach.

ICD-10 classifications
Anaesthetic, unspecifiedOther and unspecified general anaestheticsLocal anaestheticsOther complications of anaesthesiaComplication of anaesthesia during labour and delivery, unspecified
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06231316
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06231316 through Pure Global AI's free database. This phase not specified trial is sponsored by Assiut University and is currently Not yet recruiting. The study focuses on Anesthesia. Target enrollment is 100 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.